Avinger Inc (AVGR)
3.60
-0.12
(-3.22%)
USD |
NASDAQ |
May 17, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Avinger Research and Development Expense (Quarterly): 1.152M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.152M |
| September 30, 2023 | 1.044M |
| June 30, 2023 | 0.988M |
| March 31, 2023 | 1.356M |
| December 31, 2022 | 1.146M |
| September 30, 2022 | 1.086M |
| June 30, 2022 | 1.086M |
| March 31, 2022 | 1.072M |
| December 31, 2021 | 1.398M |
| September 30, 2021 | 1.397M |
| June 30, 2021 | 1.507M |
| March 31, 2021 | 1.598M |
| December 31, 2020 | 1.387M |
| September 30, 2020 | 1.417M |
| June 30, 2020 | 1.297M |
| March 31, 2020 | 1.594M |
| December 31, 2019 | 1.572M |
| September 30, 2019 | 1.371M |
| June 30, 2019 | 1.335M |
| March 31, 2019 | 1.414M |
| December 31, 2018 | 1.669M |
| Date | Value |
|---|---|
| September 30, 2018 | 1.404M |
| June 30, 2018 | 1.159M |
| March 31, 2018 | 1.777M |
| December 31, 2017 | 1.977M |
| September 30, 2017 | 2.322M |
| June 30, 2017 | 3.097M |
| March 31, 2017 | 3.923M |
| December 31, 2016 | 4.031M |
| September 30, 2016 | 3.591M |
| June 30, 2016 | 3.867M |
| March 31, 2016 | 4.047M |
| December 31, 2015 | 3.928M |
| September 30, 2015 | 3.955M |
| June 30, 2015 | 3.951M |
| March 31, 2015 | 3.86M |
| December 31, 2014 | 2.874M |
| September 30, 2014 | 2.731M |
| June 30, 2014 | 2.763M |
| March 31, 2014 | 2.856M |
| December 31, 2013 | 3.309M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.988M
Minimum
Jun 2023
1.598M
Maximum
Mar 2021
1.305M
Average
1.356M
Median
Mar 2023
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 7.452M |
| Retractable Technologies Inc | 0.1617M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |